These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19036108)

  • 21. Immunosuppressive therapy in adults with aplastic anaemia: single-institution experience from India.
    Nair V; Sharma A; Das S; Sondhi V; Sharma S
    Postgrad Med J; 2013 Sep; 89(1055):508-15. PubMed ID: 23686628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
    Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
    Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
    Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between plasma rabbit anti-thymocyte globulin concentration and immunosuppressive therapy response in patients with severe aplastic anemia.
    Narita A; Muramatsu H; Ichikawa D; Hamada M; Nishikawa E; Suzuki K; Kawashima N; Okuno Y; Nishio N; Hama A; Yamazaki H; Nakao S; Kojima S; Takahashi Y
    Eur J Haematol; 2021 Aug; 107(2):255-264. PubMed ID: 33949001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Outcomes of very severe aplastic anemia patients with different absolute neutrophil counts after frontline immnunosuppressive therapy].
    Li Y; Wu Z; Zhao X; Zhang L; Jing L; Zhou K; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Yang W; Jiang B; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):329-33. PubMed ID: 27093998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic efficacy evaluation of rabbit anti-thymocyte globulin combined with cyclosporine A in children with aplastic anemia].
    Fu RT; Xue HM; Xu HG; Huang K; Fang JP; Huang SL; Chen C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):426-30. PubMed ID: 23628047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy.
    Kao SY; Xu W; Brandwein JM; Lipton JH; Messner HA; Minden MD; Schimmer AD; Schuh AC; Yee K; Gupta V
    Br J Haematol; 2008 Dec; 143(5):738-43. PubMed ID: 19062343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
    Chen M; Liu C; Zhuang J; Zou N; Xu Y; Zhang W; Li J; Duan M; Zhu T; Cai H; Cao X; Wang S; Zhou D; Han B
    Eur J Haematol; 2016 Mar; 96(3):291-6. PubMed ID: 25996247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
    Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia.
    Luo CJ; Gao YJ; Tang JY; Zhu XH; Xue HL; Lu FJ; Pan C; Jiang H; Luo CY; Ye QD; Zhou M; Chen J
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):374-8. PubMed ID: 24807005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
    Boddu P; Garcia-Manero G; Ravandi F; Borthakur G; Jabbour E; DiNardo C; Jain N; Daver N; Pemmaraju N; Anderlini P; Parmar S; Kc D; Akosile M; Pierce SA; Champlin R; Cortes J; Kantarjian H; Kadia T
    Am J Hematol; 2017 Dec; 92(12):1295-1302. PubMed ID: 28850699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
    Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
    Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.
    Jiang J; Cai Y; Wan L; Yang J; Wang C
    Int J Hematol; 2020 Mar; 111(3):360-368. PubMed ID: 31900878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.
    McQuilten Z; Heritier S; Fox L; Fox V; Young L; Blombery P; Cunningham I; Curnow J; Higgins A; Hiwase DK; Filshie R; Firkin F; Lacaze P; Mason K; Mills AK; Pepperell D; Patil S; Stevenson W; Szer J; Waters N; Wilson K; Ting S; Wood E
    BMJ Open; 2024 Jan; 14(1):e076246. PubMed ID: 38238183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
    Scheinberg P; Nunez O; Wu C; Young NS
    Br J Haematol; 2006 Jun; 133(6):606-11. PubMed ID: 16704434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.